Amsino
Private Company
Total funding raised: $20M
Overview
Amsino is a well-established, privately-held medical device manufacturer with a significant global footprint, operating FDA-qualified manufacturing and R&D facilities in China and employing approximately 2,000 people. The company leverages a vertically integrated business model to control its supply chain, enabling competitive pricing, quality control, and rapid product development across multiple therapeutic areas. With over 25 years of experience and a portfolio supported by 52 US and Chinese patents, Amsino serves hospitals, long-term care, home care, and other clinical settings worldwide, positioning itself as a partner in care through its branded product lines and OEM capabilities.
Technology Platform
Vertically integrated manufacturing platform encompassing injection molding, mold building, tube extrusion, RF sealing, ultrasonic welding, packaging, and sterilization. Focus on disposable medical device design and production.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Amsino competes in the fragmented global market for disposable medical devices against large, diversified conglomerates (e.g., BD, Cardinal Health, Medline) and numerous niche specialists. Its competitive edge is derived from vertical integration, cost-effective manufacturing, and a comprehensive portfolio serving multiple care settings.